Researchers identified and tested study characteristics that may bias estimates of all-cause mortality risk associated with low-volume alcohol consumption using theory and evidence.
Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status
New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy before and after surgery for breast cancer
March 20, 2024